These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6191352)

  • 1. [Zinc and porphyria cutanea tarda].
    Amantea A; D'Alessandro Gandolfo L; Fonseca G; Topi G
    Quad Sclavo Diagn; 1982 Sep; 18(3):249-57. PubMed ID: 6191352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal porphyrin excretion in various types of porphyria. Thin layer chromatographic study.
    Perrot H; Boucherat M; Thivolet J
    Arch Dermatol Res; 1978; 263(1):67-73. PubMed ID: 757459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fecal porphyrin analyses in patients with porphyria cutanea tarda].
    Nonaka S; Ohgami T; Nagato N; Watanabe M; Yoshida H; Murayama F; Irifune H; Yamashita K
    Nihon Hifuka Gakkai Zasshi; 1987 Feb; 97(2):151-6. PubMed ID: 3599490
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
    Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
    Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorder of porphyrin metabolism in late porphyria cutanea tarda].
    Smirnov VS
    Vrach Delo; 1968 Jul; 7():141-2. PubMed ID: 5744377
    [No Abstract]   [Full Text] [Related]  

  • 8. Small volume plasmapheresis in the management of porphyria cutanea tarda.
    Miyauchi S; Shiraishi S; Miki Y
    Arch Dermatol; 1983 Sep; 119(9):752-5. PubMed ID: 6614963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intestinal absorption of iron observed in 2 cases of porphyria cutanea tarda].
    Cupella F; Pozzi U; Carena M; Schiavi A; Colombi R
    G Ital Med Lav; 1984; 6(5-6):259-60. PubMed ID: 6545217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid.
    de Salamanca RE; Peña ML; Olmos A; Molina C; Ladero JM
    Ann Clin Res; 1980 Dec; 12(6):279-81. PubMed ID: 6972189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease.
    Baravalle E; Prieto J
    Gastroenterology; 1983 Jun; 84(6):1483-91. PubMed ID: 6840477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron metabolism and its responses to allopurinol treatment in porphyria cutanea tarda.
    Burger T; Horváth T; Jávor T
    Acta Med Acad Sci Hung; 1978; 35(2):115-27. PubMed ID: 742338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of porphyria cutanea tarda with hemangioma of the liver.
    Iwamura K; Itakura M; Takahashi M
    Tokai J Exp Clin Med; 1983 May; 8(2):211-20. PubMed ID: 6658850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Porphyria variegata--the first case in Norway].
    Sandberg S; Brun A; Larsen S; Nyfors A; Nyfors B
    Tidsskr Nor Laegeforen; 1990 Mar; 110(9):1082-4. PubMed ID: 2330564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in zinc metabolism after burns: observations, explanations, clinical implications.
    de Haan KE; de Goeij JJ; van den Hamer CJ; Boxma H; de Groot CJ
    J Trace Elem Electrolytes Health Dis; 1992 Sep; 6(3):195-201. PubMed ID: 1282839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific metabolic aspects and the HLA system in porphyria cutanea tarda].
    Santoianni P; Ayala F; Budillon G
    G Ital Dermatol Venereol; 1984; 119(3):145-8. PubMed ID: 6746005
    [No Abstract]   [Full Text] [Related]  

  • 17. Photosensitivity and cutaneous acid hydrolases in porphyria cutanea tarda.
    Volden G; Thune P
    Ann Clin Res; 1979 Aug; 11(4):129-32. PubMed ID: 517992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the effects of reduced glutathione in subjects with acquired and congenital changes in heme biosynthesis].
    Ferioli A; De Vincentiis A; Buizza P; Pasolini G; Leali C; De Panfilis G; Alessio L
    Minerva Med; 1992 May; 83(5):269-75. PubMed ID: 1589131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carbohydrate turnover and capillary changes in porphyria cutanea tarda].
    Lisi P
    G Ital Dermatol Venereol; 1984; 119(3):157-9. PubMed ID: 6746008
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietic protoporphyria presenting in adulthood.
    Fallon JD; Kvedar JC; Margolis RJ; Pathak MA
    Arch Dermatol; 1989 Sep; 125(9):1286-7. PubMed ID: 2774610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.